I can see his point. Right now a large partner can get about 10% of the company with the C shares. At bit of a depressed price without raising the ire of shareholders if the stock was $4 to $5 now.
They could have come to some agreement in June pending a JA or other milestone. So let’s say based on (if true or not) it is a $3.50 agreement for 10% it would be accepted by shareholders. A buyout would be years down the line if all solid tumors operable and inoperable are factored in.
Market Data 
Markets 
AI
